ICOS and clear cell renal carcinoma: For patients with melanoma (15–17), gastric (18, 19) and liver cancer (20), gynecological (21, 22) and breast cancer (23, 24), and renal clear cell carcinoma (25), higher ICOS expression predicted much worse survival.